4 Results for "

RXR-antagonistic activities

" in MedChemExpress (MCE) Product Catalog:
Products (4)

4 Results for "RXR-antagonistic activities" in MCE Product Catalog:

Cat. No.: HY-108521
CAS No.: 188844-34-0
Purity:  99.87%
Research Areas:  

Metabolic Disease Cancer

HX531 is an orally active RXR antagonist with an IC50 of 18 nM. HX531 upregulates the p53-p21Cip1 pathway. HX531 abrogates the anti-apoptotic effect of t-RA. HX531 exerts anti-obesity, anti-diabetic and anti-melanoma activities .
loading...
    loading...
Cat. No.: HY-144377
CAS No.: 3010910-40-1
Purity:  99.94%
Target:  

RAR/RXR

RXR antagonist 1 (compound 6a) is a retinoid X receptor (RXR) modulator. RXR antagonist 1 shows potent RXR-antagonistic activity, with a pA2 of 8.06. RXR antagonist 1 can be used for type 2 diabetes research .
loading...
    loading...
Cat. No.: HY-180181
Target:  

RAR/RXR

Research Areas:  

Metabolic Disease Cancer

RXR antagonist 6 (Compound 34) is a selective partial retinoid X receptor (RXR) antagonist. RXR antagonist 6 shows no agonistic activity for any of the human RXRα/β/γ subtypes but it can strongly inhibit the receptor activation induced by full agonists of RXR (such as Bezafibrate (HY-B0637)) with an IC50 of 2.7 μM. RXR antagonist 6 can enhance PMA (HY-18739)-induced THP-1 cell differentiation. RXR antagonist 6 can be used for the research of cancer, metabolic and neurological disease, such as lymphoma .
loading...
    loading...
Cat. No.: HY-108521R
CAS No.: 188844-34-0
HX531 (Standard) is the analytical standard of HX531 (HY-108521). This product is intended for research and analytical applications. HX531 is an orally active RXR antagonist with an IC50 of 18 nM. HX531 upregulates the p53-p21Cip1 pathway. HX531 abrogates the anti-apoptotic effect of t-RA. HX531 exerts anti-obesity, anti-diabetic and anti-melanoma activities .
loading...
    loading...